Minor
TNP-2092 Administered Via IA Injection in PJI Participants
Primary and study completion pushed from Aug 2026 to Jan 2027
TenNor Therapeutics Inc.Phase 1/2 NCT06889701 Registry history of NCT06889701 on ClinicalTrials.gov (opens the registry)
Updated